We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+31.21%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.62B
AUM Growth
+$785M
Cap. Flow
+$549M
Cap. Flow %
34.01%
Top 10 Hldgs %
21.48%
Holding
388
New
151
Increased
50
Reduced
46
Closed
130

Top Buys

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$40.9M
2
PCG icon
PG&E
PCG
+$39.9M
3
GSAH.U
GS Acquisition Holdings Corp II Units, each consisting of one share of Class A Common Stock and one-
GSAH.U
+$28.4M
4
NFLX icon
Netflix
NFLX
+$26.1M
5
HBI
Hanesbrands
HBI
+$24.7M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$25.5M
2
TGT icon
Target
TGT
+$18.9M
3
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
+$17.1M
4
UTZ icon
Utz Brands
UTZ
+$17M
5
AMZN icon
Amazon
AMZN
+$11.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.3%
2 Communication Services 7.55%
3 Industrials 7.38%
4 Technology 6.37%
5 Healthcare 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
201
Protagonist Therapeutics
PTGX
$8.92B
$872K 0.05%
+49,359
New +$619K
PDCE
202
DELISTED
PDC Energy, Inc.
PDCE
$866K 0.05%
69,652
-20,000
-22% -$239K
MLCO icon
203
CALL
Melco Resorts & Entertainment
MLCO
$2.24B
$854K 0.05%
55,000
+32,700
+147% +$506K
KURA icon
204
Kura Oncology
KURA
$826M
$853K 0.05%
+52,335
New +$755K
TFSL icon
205
TFS Financial
TFSL
$5.06B
$805K 0.05%
+56,258
New +$810K
ATNM icon
206
Actinium Pharmaceuticals
ATNM
$26.3M
$756K 0.05%
+71,680
New +$543K
TRIP icon
207
TripAdvisor
TRIP
$1.65B
$725K 0.04%
38,140
-6,690
-15% -$128K
DKNG icon
208
DraftKings
DKNG
$11.8B
$708K 0.04%
+21,296
New +$589K
XEC
209
DELISTED
CIMAREX ENERGY CO
XEC
$665K 0.04%
+24,201
New +$600K
TCRR
210
CALL
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$627K 0.04%
+40,800
New +$471K
MYOK
211
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$582K 0.04%
+6,021
New +$502K
GLD icon
212
SPDR Gold Trust
GLD
$133B
$545K 0.03%
3,258
-1,742
-35% -$281K
VNTR
213
DELISTED
Venator Materials PLC
VNTR
$537K 0.03%
299,997
+226,068
+306% +$352K
YELL
214
CALL
DELISTED
Yellow Corporation Common Stock
YELL
$524K 0.03%
+283,000
New +$461K
IART icon
215
Integra LifeSciences
IART
$1.33B
$519K 0.03%
+11,039
New +$543K
GAP
216
The Gap Inc
GAP
$7.34B
$519K 0.03%
+41,092
New +$370K
XLB icon
217
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
$517K 0.03%
+18,338
New +$483K
CPRX
218
DELISTED
Catalyst Pharmaceutical
CPRX
$499K 0.03%
107,951
-346,822
-76% -$1.56M
DIS icon
219
Walt Disney
DIS
$167B
$490K 0.03%
4,397
-12,684
-74% -$1.4M
XAIR icon
220
CALL
Beyond Air
XAIR
$3.91M
$489K 0.03%
+585
New +$1.81M
UTZ icon
221
CALL
Utz Brands
UTZ
$1.25B
$487K 0.03%
153,284
-310,182
-67% -$3.59M
XLF icon
222
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
$478K 0.03%
+20,649
New +$469K
XLV icon
223
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$455K 0.03%
4,542
-4,845
-52% -$478K
GLRE icon
224
Greenlight Captial
GLRE
$552M
$443K 0.03%
67,927
-21,002
-24% -$137K
MU icon
225
Micron Technology
MU
$988B
$437K 0.03%
8,489
-42,623
-83% -$2.01M
7 8
9
10 11

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q2 2020 Portfolio in Review

As of Q2 2020, J. Goldman & Co held 388 positions worth $1.62B, up 95% from $830M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

J. Goldman & Co deployed $549M of net new capital in Q2 2020, opening 151 new positions and adding to 50 existing holdings. Its largest new stake was Mondelez International: 795,659 shares worth $40.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 14% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $25.5M trimmed.

  • J. Goldman & Co's largest Q2 2020 buy was Mondelez International: 795,659 shares worth $40.7M.
  • J. Goldman & Co added most to Netflix in Q2 2020, an estimated $26.1M increase.
  • J. Goldman & Co's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $25.5M.
  • J. Goldman & Co fully exited Target in Q2 2020, selling an estimated $18.9M.
  • J. Goldman & Co's ten largest holdings make up 21% of its $1.62B portfolio in Q2 2020.
  • J. Goldman & Co opened 151 new positions and closed 130 in Q2 2020.
  • J. Goldman & Co's portfolio value rose 95% quarter-over-quarter to $1.62B.

Based on J. Goldman & Co's 13F filing for Q2 2020, filed 14 Aug 2020.